<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04993053</url>
  </required_header>
  <id_info>
    <org_study_id>TFNA - 29BRC21.0076</org_study_id>
    <nct_id>NCT04993053</nct_id>
  </id_info>
  <brief_title>Use of Cemented TFNA Nail Augmentation in the Treatment of Trochanterian Rock Fractures</brief_title>
  <acronym>TFNA</acronym>
  <official_title>Use of Cemented TFNA Nail Augmentation in the Treatment of Trochanterian Rock Fractures in Patients Over 65 Years of Age</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Brest</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Brest</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intramedullary nailing is the standard treatment of trochanteric fractures. Mechanical&#xD;
      failure such as cut-out and cut-through are associated with high rates of revision surgery,&#xD;
      functional impairment and mortality. Augmentation of the implant have shown encouraging&#xD;
      results in reducing the number of mechanical failures. The aim of the study was to evaluate&#xD;
      the rate of mechanical failure of the cement augmented screws of TFNA nails.&#xD;
&#xD;
      A descriptive, retrospective, multi-operator, single-centre study was performed at our level&#xD;
      1 trauma centre. Patients were included if they were &gt; 65 years of age, presented with a&#xD;
      trochanteric fracture treated with an augmented TFNA nail. The primary outcome was fixation&#xD;
      failure rate (cut-out or cut-through) at 3 and 6 postoperative months. Secondary endpoints&#xD;
      were intraoperative data, clinical scores, and radiographic analysis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 20, 2019</start_date>
  <completion_date type="Actual">September 15, 2020</completion_date>
  <primary_completion_date type="Actual">June 3, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Fixation failure rate (cut-out or cut-through)</measure>
    <time_frame>change at 3 and 6 postoperative months</time_frame>
    <description>On X rays</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual Analogue Scale score</measure>
    <time_frame>at 3 and 6 postoperative months</time_frame>
    <description>the minimum is 0 and maximum 10, higher scores mean a worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>analysis evaluating quality of reduction</measure>
    <time_frame>once</time_frame>
    <description>On X rays</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Augmentation volume</measure>
    <time_frame>once</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>length of surgery</measure>
    <time_frame>at 3 and 6 postoperative months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>radiation exposure</measure>
    <time_frame>once</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>duration of hospitalisation</measure>
    <time_frame>once</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative adverse events</measure>
    <time_frame>once</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EuroQoL 5-Dimensions score</measure>
    <time_frame>change at 3 and 6 postoperative months</time_frame>
    <description>the minimum is 5 and maximum 15, higher scores mean a worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Parker Mobility Score</measure>
    <time_frame>at 3 and 6 postoperative months</time_frame>
    <description>the minimum is 0 and maximum 9, higher scores mean a better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Harris Hip Score</measure>
    <time_frame>at 3 and 6 postoperative months</time_frame>
    <description>the minimum is 0 and maximum 100, higher scores mean a betteroutcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the tip-apex distance</measure>
    <time_frame>once</time_frame>
    <description>On X rays</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>TFNA screw position</measure>
    <time_frame>once</time_frame>
    <description>On X rays</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>distribution of cement on either side of the cervicocephalic screw</measure>
    <time_frame>once</time_frame>
    <description>On X rays</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative complications</measure>
    <time_frame>at 3 and 6 postoperative months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the need for revision surgery</measure>
    <time_frame>at 3 and 6 postoperative months</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">61</enrollment>
  <condition>the Cement Augmented Screws of TFNA Nails</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The study population consisted of 61 patients. The analyses were therefore based on 45&#xD;
        patients (Table 1). The 38 women and 7 men had a mean age of 82.84 years (65-102, 9.50) and&#xD;
        most had sustained AO/OTA 31-A1.2 fractures.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  &gt; 65 years of age&#xD;
&#xD;
          -  a trochanteric fracture that occurred through a low-energy mechanism&#xD;
&#xD;
          -  an augmented TFNA nail&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pathological fracture&#xD;
&#xD;
          -  open fracture&#xD;
&#xD;
          -  hips with pre-existing deformities other than osteoarthritis&#xD;
&#xD;
          -  a history of hip surgery&#xD;
&#xD;
          -  an insufficient quantity of injected cement (&lt; 3 mL).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHU de Brest</name>
      <address>
        <city>Brest</city>
        <zip>29609</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 6, 2021</study_first_submitted>
  <study_first_submitted_qc>July 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 6, 2021</study_first_posted>
  <last_update_submitted>July 28, 2021</last_update_submitted>
  <last_update_submitted_qc>July 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>TFNA</keyword>
  <keyword>Hip fracture</keyword>
  <keyword>Augmentation</keyword>
  <keyword>Cement</keyword>
  <keyword>Cut-out</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All collected data that underlie results in a publication.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>Data will be available beginning three years and ending five years following the final study report completion.</ipd_time_frame>
    <ipd_access_criteria>Data access request will be reviewed by the internal committee of Brest University Hospital. Requestor will be required to sign and complete a data access agreement.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

